Search

Phuong N. Huynh

Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1641, 1644
Total Applications
2195
Issued Applications
1131
Pending Applications
251
Abandoned Applications
828

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5603161 [patent_doc_number] => 20060293506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Antibodies directed to PDGFD and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/109181 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 26087 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20060293506.pdf [firstpage_image] =>[orig_patent_app_number] => 11109181 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/109181
Antibodies directed to PDGFD and uses thereof Apr 17, 2005 Abandoned
Array ( [id] => 4652146 [patent_doc_number] => 20080039402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Peptides and Peptidomimetics Binding to Cd23' [patent_app_type] => utility [patent_app_number] => 10/594674 [patent_app_country] => US [patent_app_date] => 2005-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11605 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039402.pdf [firstpage_image] =>[orig_patent_app_number] => 10594674 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594674
Peptides and peptidomimetics binding to CD23 Apr 4, 2005 Issued
Array ( [id] => 7193056 [patent_doc_number] => 20050163779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor' [patent_app_type] => utility [patent_app_number] => 11/097334 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10033 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163779.pdf [firstpage_image] =>[orig_patent_app_number] => 11097334 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/097334
Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor Apr 3, 2005 Issued
Array ( [id] => 543064 [patent_doc_number] => 07163802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use' [patent_app_type] => utility [patent_app_number] => 11/090353 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 11953 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163802.pdf [firstpage_image] =>[orig_patent_app_number] => 11090353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/090353
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use Mar 24, 2005 Issued
Array ( [id] => 6951767 [patent_doc_number] => 20050226861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Immunogen adherence inhibitor and method of making and using same' [patent_app_type] => utility [patent_app_number] => 11/085674 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9052 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226861.pdf [firstpage_image] =>[orig_patent_app_number] => 11085674 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/085674
Immunogen adherence inhibitor and method of making and using same Mar 20, 2005 Abandoned
Array ( [id] => 5819989 [patent_doc_number] => 20060024302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/074373 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26558 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024302.pdf [firstpage_image] =>[orig_patent_app_number] => 11074373 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/074373
Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same Mar 6, 2005 Abandoned
Array ( [id] => 5159446 [patent_doc_number] => 20070172490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Leukocyte stimulation matrix' [patent_app_type] => utility [patent_app_number] => 10/591470 [patent_app_country] => US [patent_app_date] => 2005-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5785 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172490.pdf [firstpage_image] =>[orig_patent_app_number] => 10591470 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591470
Leukocyte stimulation matrix Mar 3, 2005 Abandoned
Array ( [id] => 6957910 [patent_doc_number] => 20050214280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Method for inhibiting tumor formation and growth' [patent_app_type] => utility [patent_app_number] => 11/068888 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10555 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214280.pdf [firstpage_image] =>[orig_patent_app_number] => 11068888 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/068888
Method for inhibiting tumor formation and growth Mar 1, 2005 Abandoned
Array ( [id] => 5296019 [patent_doc_number] => 20090010945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Partially Loaded Antibodies And Methods Of Their Conjugation' [patent_app_type] => utility [patent_app_number] => 10/591743 [patent_app_country] => US [patent_app_date] => 2005-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 28481 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010945.pdf [firstpage_image] =>[orig_patent_app_number] => 10591743 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591743
Partially loaded antibodies and methods of their conjugation Mar 1, 2005 Issued
Array ( [id] => 267022 [patent_doc_number] => 07566546 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Modulators of angiogenesis and tumorigenesis' [patent_app_type] => utility [patent_app_number] => 11/060659 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 20264 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566546.pdf [firstpage_image] =>[orig_patent_app_number] => 11060659 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/060659
Modulators of angiogenesis and tumorigenesis Feb 15, 2005 Issued
Array ( [id] => 5793564 [patent_doc_number] => 20060014245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Fusion proteins containing recombinant cytotoxic RNAses' [patent_app_type] => utility [patent_app_number] => 11/056182 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12109 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014245.pdf [firstpage_image] =>[orig_patent_app_number] => 11056182 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/056182
Fusion proteins containing recombinant cytotoxic RNAses Feb 13, 2005 Issued
Array ( [id] => 651082 [patent_doc_number] => 07112659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-26 [patent_title] => 'OB fusion protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/054085 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13372 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112659.pdf [firstpage_image] =>[orig_patent_app_number] => 11054085 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/054085
OB fusion protein compositions and methods Feb 7, 2005 Issued
Array ( [id] => 6911861 [patent_doc_number] => 20050175619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Methods of producing antibody conjugates' [patent_app_type] => utility [patent_app_number] => 11/050981 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10823 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175619.pdf [firstpage_image] =>[orig_patent_app_number] => 11050981 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050981
Methods of producing antibody conjugates Feb 3, 2005 Abandoned
Array ( [id] => 8784512 [patent_doc_number] => 08431355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Process for screening glycoform-specific antibodies' [patent_app_type] => utility [patent_app_number] => 10/588220 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 72 [patent_no_of_words] => 17672 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10588220 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/588220
Process for screening glycoform-specific antibodies Feb 3, 2005 Issued
Array ( [id] => 7184765 [patent_doc_number] => 20050191671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Isolated human transporter cofactor proteins, nucleic acid molecules encoding human transporter cofactor proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/043932 [patent_app_country] => US [patent_app_date] => 2005-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19960 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191671.pdf [firstpage_image] =>[orig_patent_app_number] => 11043932 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/043932
Isolated human transporter cofactor proteins, nucleic acid molecules encoding human transporter cofactor proteins and uses thereof Jan 27, 2005 Abandoned
Array ( [id] => 6374303 [patent_doc_number] => 20100075891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Novel polynucleotides encoding polypeptides and methods using same' [patent_app_type] => utility [patent_app_number] => 11/043770 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 299 [patent_figures_cnt] => 299 [patent_no_of_words] => 236427 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11043770 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/043770
Polynucleotides encoding polypeptides and methods using same Jan 26, 2005 Issued
Array ( [id] => 4955380 [patent_doc_number] => 20080188404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement' [patent_app_type] => utility [patent_app_number] => 10/597373 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 12296 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188404.pdf [firstpage_image] =>[orig_patent_app_number] => 10597373 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/597373
Hybrid and chimeric polypeptides that regulate activation of complement Jan 20, 2005 Issued
Array ( [id] => 4955380 [patent_doc_number] => 20080188404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement' [patent_app_type] => utility [patent_app_number] => 10/597373 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 12296 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188404.pdf [firstpage_image] =>[orig_patent_app_number] => 10597373 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/597373
Hybrid and chimeric polypeptides that regulate activation of complement Jan 20, 2005 Issued
Array ( [id] => 7192980 [patent_doc_number] => 20050163770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Immunological reagent specifically interacting with the extracellular domain of the human zeta chain' [patent_app_type] => utility [patent_app_number] => 11/036098 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17962 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163770.pdf [firstpage_image] =>[orig_patent_app_number] => 11036098 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/036098
Immunological reagent specifically interacting with the extracellular domain of the human zeta chain Jan 17, 2005 Abandoned
Array ( [id] => 5545389 [patent_doc_number] => 20090155266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases' [patent_app_type] => utility [patent_app_number] => 10/586254 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21421 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155266.pdf [firstpage_image] =>[orig_patent_app_number] => 10586254 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586254
Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases Jan 17, 2005 Abandoned
Menu